Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2.
Wells L, Vierra C, Hardman J, Han Y, Dimas D, Gwarada-Phillips LN, Blackeye R, Eggers DK, LaBranche CC, Král P, McReynolds KD.
Wells L, et al. Among authors: mcreynolds kd.
Adv Ther (Weinh). 2021 Apr;4(4):2000210. doi: 10.1002/adtp.202000210. Epub 2021 Feb 12.
Adv Ther (Weinh). 2021.
PMID: 33786368
Free PMC article.